Top Markets
#1 Black Phoenix Black Phoenix +17,812.10%
#2 Cash Dog in Hood Cash Dog in Hood +6,493.59%
#3 up up +49.01%
#4 Arrow Arrow +48.53%
#5 Quai Network Quai Network +39.70%
#6 Octra Octra +37.04%
#7 Derive Derive +34.20%
#8 B3 (Base) B3 (Base) +31.77%
#9 Block Street Block Street +31.33%
#10 EVAA Protocol EVAA Protocol +28.76%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Clasificación en acciones #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Precio por acción
$4.66
Capitalización bursátil
$43.92M
Cambio (1 día)
-0.63%
Cambio (1 año)
338.04%
País
FR
Comercio Theranexus Société Anonyme (ALTHX)

Categoría

Healthcare
Historial del precio de la acción de Theranexus Société Anonyme (ALTHX)
Precio más alto de cierre: $4.28 el 2026-07-01

Precio más bajo de cierre: $18.24 el 2017-10-01
Historial del precio de la acción de Theranexus Société Anonyme desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 258.45%
2025 104.46%
2024 -56.41%
2023 -31.97%
2022 -66.49%
2021 -75.68%
2020 623.94%
2019 -82.16%
2018 -1.64%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $49.07 -28.82%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $476.31 0.84%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $656.12 14.99%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $275.78 36.87%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $859.43 53.12%
NL